Skip to main navigation
Repare Therapeutics
  • Company
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Science
    • Discovery Platform
    • Therapeutic Focus
    • Scientific References
  • Pipeline
    • Development Pipeline
    • Camonsertib ATR Inhibitor
    • RP-6306 PKMYTI Inhibitor
    • Polθ Inhibitor
  • Clinical Trials
    • Clinical Trials Overview
  • Careers
    • Job Opportunities
    • Our Culture
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • Contact IR
Select Page

Press Releases

Press Releases

Mar 14, 2023
Repare Therapeutics Announces Plenary Oral Presentation at the 2023 AACR Annual Meeting on Camonsertib and Additional Data Presentations on RP-6306
Feb 28, 2023
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 02, 2023
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Jan 19, 2023
Repare Therapeutics Receives $1.5 Million (¥200 million) Payment from Ono Pharmaceuticals
Media & IR Contact
Investor Contact

Robin Garner
Investor Relations
Contact Us

Media Contact

David Rosen
Argot Partners
[email protected]

Helpful Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
Company
  • About Us
  • Leadership
  • Partnering
  • Contact
Science
  • Discovery Platform
  • Therapeutic Focus
  • Scientific References
Pipeline
  • Development Pipeline
  • Camonsertib ATR Inhibitor
  • RP-6306 PKMYTI Inhibitor
  • Polθ Inhibitor
Clinical Trials
  • Clinical Trials Overview
Careers
  • Job Opportunities
  • Our Culture
Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Repare Therapeutics logo
© 2023 Repare Therapeutics
  • Privacy Policy
  • Terms of Use
  • Cookie Policy